ASweetLife Team, Author at ASweetLife

FDA May Stop Avandia Trials

The Food and Drug Administration (FDA) is considering stopping a safety study involving thousands of patients taking GlaxoSmithKline PLC's Avandia according to the Wall Street Journal. Avandia has been linked to an increased risk of heart attack. If the trial is stopped, the FDA will also consider asking Glaxo to stop selling the drug, a decision that could also...

Successful First Trial for Artificial Pancreas

The new artificial pancreas system developed at Boston University was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of type 1 diabetic patients in the first clinical trial conducted at Massachusetts General Hospital....

Sanofi-Aventis Diabetes Monotherapy Meets Phase III Study Endpoint Successfully

Sanofi-aventis announced the results of the first placebo-controlled study of the GetGoal Phase III clinical trial program of lixisenatide (AVE0010), a once-daily GLP-1 agonist developed for patients with type 2 diabetes. The 12-week study involved 361 patients with type 2 diabetes not currently receiving glucose-lowering therapy and with HbA1c between 7 and 10%...

Wash Your Hands

Lady MacBeth washed her hands after she'd bloodied them. Diabetics should wash before. Having clean hands is always a smart idea and it's a particularly good idea to wash up before you check your blood sugar.

Roche Expands Diabetes Portfolio

Roche announced the acquisition of Medingo Ltd., a company engaged in the development of a semi-disposable insulin patch pump. The new Medingo Ltd. micro pump insulin delivery system consists of two parts: a semi-disposable insulin dispensing patch and a remote control, which allows for discreet personalized insulin delivery...

Researchers Cure Type 1 Diabetes in Mice

Using a sophisticated nanotechnology-based “vaccine,” researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes...

Sanofi-Aventis and CureMD sign $335M Deal on Diabetes Cure Development

Sanofi-aventis announced that it has signed a global license agreement with CureDM Group on a novel human peptide, Pancreate™, which could restore a patients’ ability to produce insulin and other pancreatic hormones in both type 1 and type 2 diabetes. Pancreate™ is a bioactive peptide sequence of a naturally occurring human protein that has been shown...

Soy Supplements Do Not Benefit Type 2 Diabetics

A new study out of Hong Kong suggests that soy supplements do not benefit type 2 diabetics. According to a Reuters report, previous lab research has suggested that soy proteins and soy isoflavones -- "phytoestrogen" compounds that are structurally similar to human estrogen -- may help control blood sugar levels...

Real Eggs Have no Carbs

If you're putting together an Easter basket for a child with diabetes, try replacing sugary candies with colorfully dyed hard-boiled eggs. If that seems too boring, add in a few inedible toys -- like a stuffed animal or a small game. Remember: "fun" doesn't have to mean "sweet," and this is true for adults as well.

Sanofi-aventis & AgaMatrix to Develop New Blood Glucose Monitoring Solutions

Sanofi-aventis announced that they have signed an agreement with AgaMatrix Inc. for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes care with the aim to simplify patients’ and healthcare providers’ diabetes management experience....